These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 22509094
1. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice. Liu Y, Jiang J, Xiao H, Wang X, Li Y, Gong Y, Wang D, Huang Y. Mol Vis; 2012; 18():624-33. PubMed ID: 22509094 [Abstract] [Full Text] [Related]
2. Effects of topical sphingosine-1-phosphate 1 receptor agonist on corneal allograft in mice. Jia L, Liu Y, Wang L, Zhu J, Huang Y. Cornea; 2014 Apr; 33(4):398-404. PubMed ID: 24573171 [Abstract] [Full Text] [Related]
3. Influence of combined treatment of low dose rapamycin and cyclosporin A on corneal allograft survival. Stanojlovic S, Schlickeiser S, Appelt C, Vogt K, Schmitt-Knosalla I, Haase S, Ritter T, Sawitzki B, Pleyer U. Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1447-56. PubMed ID: 20574747 [Abstract] [Full Text] [Related]
4. Systemic application of sphingosine 1-phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice. Zhu J, Liu Y, Pi Y, Jia L, Wang L, Huang Y. Acta Ophthalmol; 2014 Feb; 92(1):e12-21. PubMed ID: 23910624 [Abstract] [Full Text] [Related]
5. Topical application of sphingosine 1-phosphate receptor 1 prolongs corneal graft survival in mice. Zhu J, Liu Y, Huang Y. Mol Med Rep; 2015 May; 11(5):3800-7. PubMed ID: 25607596 [Abstract] [Full Text] [Related]
6. The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection. Commodaro AG, Pedregosa JF, Peron JP, Brandão W, Rizzo LV, Bueno V. Clinics (Sao Paulo); 2012 Jul; 67(7):805-13. PubMed ID: 22892927 [Abstract] [Full Text] [Related]
7. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation. Wang X, Wang W, Xu J, Le Q. Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787 [Abstract] [Full Text] [Related]
8. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Hwang MW, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, Hara M, Sasayama S. Circulation; 1999 Sep 21; 100(12):1322-9. PubMed ID: 10491378 [Abstract] [Full Text] [Related]
9. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K. J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152 [Abstract] [Full Text] [Related]
10. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Nikolova Z, Hof A, Baumlin Y, Hof RP. Transpl Immunol; 2001 Feb 01; 8(4):267-77. PubMed ID: 11316070 [Abstract] [Full Text] [Related]
11. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro. Liu Y, Jiang J, Xiao H, Wang X, Li Y, Gong Y, Huang Y. Int J Mol Med; 2012 Jul 01; 30(1):211-9. PubMed ID: 22576630 [Abstract] [Full Text] [Related]
12. Significant prolongation of orthotopic corneal-graft survival in FTY720-treated mice. Zhang EP, Müller A, Ignatius R, Hoffmann F. Transplantation; 2003 Nov 27; 76(10):1511-3. PubMed ID: 14657695 [Abstract] [Full Text] [Related]
13. Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells. Wang X, Wang W, Xu J, Hong J, Le Q. Exp Clin Transplant; 2013 Feb 27; 11(1):56-62. PubMed ID: 22769982 [Abstract] [Full Text] [Related]
14. Effects of long-term administration of low-dose FTY720 on survival of murine cardiac allograft. Cheng Q, Li D, Liang H, Yang H, Lei D, Gao D, Long X, Chen Y, Zhu P, Chen X. J Huazhong Univ Sci Technolog Med Sci; 2012 Apr 27; 32(2):199-204. PubMed ID: 22528220 [Abstract] [Full Text] [Related]
15. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. Tahvildari M, Omoto M, Chen Y, Emami-Naeini P, Inomata T, Dohlman TH, Kaye AE, Chauhan SK, Dana R. Transplantation; 2016 Mar 27; 100(3):525-32. PubMed ID: 26881788 [Abstract] [Full Text] [Related]
16. Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival. Heng Y, Ma Y, Yin H, Duan L, Xiong P, Xu Y, Feng W, Fang M, Tan Z, Chen Y, Zheng F, Gong F. Transpl Int; 2010 Dec 27; 23(12):1259-70. PubMed ID: 20536794 [Abstract] [Full Text] [Related]
17. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo. Wu T, Zhang L, Xu K, Sun C, Lei T, Peng J, Liu G, Wang R, Zhao Y. Transpl Immunol; 2012 Aug 27; 27(1):30-8. PubMed ID: 22613676 [Abstract] [Full Text] [Related]
18. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF. Transplantation; 1997 Dec 15; 64(11):1525-31. PubMed ID: 9415551 [Abstract] [Full Text] [Related]
19. Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist. Gao M, Liu Y, Xiao Y, Han G, Jia L, Wang L, Lei T, Huang Y. PLoS One; 2014 Dec 15; 9(9):e105693. PubMed ID: 25216235 [Abstract] [Full Text] [Related]
20. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant]. Shi W, Xie L, Wang S. Zhonghua Yan Ke Za Zhi; 2002 Aug 15; 38(8):502-5. PubMed ID: 12410993 [Abstract] [Full Text] [Related] Page: [Next] [New Search]